Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases

[1]  Y. Nakagawa,et al.  Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. , 2009, International journal of molecular medicine.

[2]  Y. Nakagawa,et al.  Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC) , 2009, Clinical and Experimental Medicine.

[3]  B. Tycko,et al.  Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation , 2008, Nature Genetics.

[4]  K. Lesch,et al.  Functional Analysis of a Potassium-Chloride Co-Transporter 3 (SLC12A6) Promoter Polymorphism Leading to an Additional DNA Methylation Site , 2008, Neuropsychopharmacology.

[5]  R. Romero,et al.  Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. , 2008, Human molecular genetics.

[6]  Thomas Lengauer,et al.  Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping , 2008, Nucleic acids research.

[7]  L. Milani,et al.  Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. , 2008, Human molecular genetics.

[8]  L. Milani,et al.  An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. , 2007, Human molecular genetics.

[9]  U. Broeckel,et al.  Pediatric inflammatory bowel disease: clinical and molecular genetics. , 2007, Inflammatory bowel diseases.

[10]  J. Schramm,et al.  Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. , 2007, The Journal of molecular diagnostics : JMD.

[11]  W. Reik.  Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[12]  J. Bene,et al.  No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples. , 2007, World journal of gastroenterology.

[13]  M. Sathiyasekaran,et al.  Crohn’s disease , 2006, Indian journal of pediatrics.

[14]  Arturas Petronis,et al.  Epigenetics and twins: three variations on the theme. , 2006, Trends in genetics : TIG.

[15]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.

[16]  E. Loftus.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.

[17]  R. Kolodner,et al.  Regulation of the Human MSH6 Gene by the Sp1 Transcription Factor and Alteration of Promoter Activity and Expression by Polymorphisms , 2003, Molecular and Cellular Biology.

[18]  Robert A. Waterland,et al.  Transposable Elements: Targets for Early Nutritional Effects on Epigenetic Gene Regulation , 2003, Molecular and Cellular Biology.

[19]  K A Baggerly,et al.  Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.

[20]  A. Petronis,et al.  Epigenetics of inflammatory bowel disease , 2000, Gut.

[21]  Z. Siegfried,et al.  Spl elements protect a CpG island from de novo methylation , 1994, Nature.

[22]  D. Franchimont,et al.  Crohn's Disease , 1976, The Lancet.

[23]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[24]  J. Issa,et al.  Optimizing annealing temperature overcomes bias in bisulfite PCR methylation analysis. , 2007, BioTechniques.